Quick Answer
ACADIA PHARMACEUTICALS INC reported Total Revenue of $1.07 billion for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed an increase of +11.9% in Total Revenue from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: $380.0 thousand | Q1 2013: $417.0 thousand | Q2 2013: $451.0 thousand | Q3 2013: $240.0 thousand | Q4 2013: $37.0 thousand | Q1 2014: $30.0 thousand | Q2 2014: $28.0 thousand | Q3 2014: $15.0 thousand | Q4 2014: $47.0 thousand | Q1 2015: $4.0 thousand | Q2 2015: $1.0 thousand | Q3 2015: $39.0 thousand | Q4 2015: $17.0 thousand | Q1 2016: $4.0 thousand | Q2 2016: $97.0 thousand | Q3 2016: $5.27 million | Q4 2016: $11.96 million | Q1 2017: $15.29 million | Q2 2017: $30.48 million | Q2 2017: $30.48 million | Q3 2017: $35.58 million | Q3 2017: $35.58 million | Q4 2017: $43.56 million | Q1 2018: $48.87 million | Q1 2018: $48.87 million | Q2 2018: $57.06 million | Q3 2018: $58.31 million | Q1 2019: $62.96 million | Q2 2019: $83.21 million | Q3 2019: $94.59 million | Q1 2020: $90.07 million | Q2 2020: $110.10 million | Q3 2020: $120.58 million | Q1 2021: $106.55 million | Q2 2021: $115.22 million | Q3 2021: $131.61 million | Q1 2022: $115.47 million | Q2 2022: $134.56 million | Q3 2022: $130.71 million | Q1 2023: $118.46 million | Q2 2023: $165.24 million | Q3 2023: $211.70 million | Q1 2024: $205.83 million | Q2 2024: $241.96 million | Q3 2024: $250.40 million | Q1 2025: $244.32 million | Q2 2025: $264.57 million | Q3 2025: $278.63 million.
- Over the full 19 years of available data (2009 to 2025), ACADIA PHARMACEUTICALS INC's Total Revenue has grown by 16,644.9%.
- Historical annual values: Fiscal year 2025: $1.07 billion | Fiscal year 2024: $957.80 million | Fiscal year 2023: $726.44 million | Fiscal year 2022: $517.24 million | Fiscal year 2021: $484.15 million | Fiscal year 2020: $441.76 million | Fiscal year 2019: $339.08 million | Fiscal year 2018: $223.81 million | Fiscal year 2017: $124.90 million | Fiscal year 2017: $124.90 million | Fiscal year 2016: $17.33 million | Fiscal year 2016: $17.33 million | Fiscal year 2015: $61.0 thousand | Fiscal year 2014: $120.0 thousand | Fiscal year 2013: $1.15 million | Fiscal year 2012: $4.91 million | Fiscal year 2011: $2.07 million | Fiscal year 2010: $42.14 million | Fiscal year 2009: $6.40 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: